Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing and familial implications in breast-ovarian cancer families.

Maturitas - 1 Aug 2014

Oosterwijk Jan C, de Vries Jakob, Mourits Marian J, de Bock Geertruida H

Abstract excerpt

DNA-testing for BRCA1 and BRCA2 has become incorporated in the diagnostic procedure of patients with breast and/or ovarian cancer. Since 1994 an immense amount of information has been gathered on mutation spectra, mutation risk assessment, cancer risks for mutation carriers, factors that modify t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 24894332
DOI: 10.1016/j.maturitas.2014.05.002

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24894332-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing and familial implications in breast-ovarian cancer families.PMID 24894332Read ↗

Risk assessment & genetic testing.Semantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].Semantic proximity Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

Mutations of BRCA genes in hereditary breast and ovarian cancer.Semantic proximity Read ↗

Clinical implications of genetic testing for inherited breast and ovarian cancer risk.Semantic proximity Read ↗

[Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].Semantic proximity Read ↗

[Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].Semantic proximity Read ↗

[Who must be referred for genetic counseling?]Semantic proximity Read ↗

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsSemantic proximity Read ↗

Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.Semantic proximity Read ↗

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.